Orchid Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	50,037	24,469	39,363	52,994	15,643	11,641
Market Cap Growth	39.91%	-37.84%	-25.72%	238.77%	34.38%	-88.15%
Enterprise Value	52,831	25,800	38,574	53,964	18,909	14,449
Last Close Price	986.55	482.45	776.10	1044.85	383.25	285.20
PE Ratio	243.59	119.09	39.50	57.50	33.77	-
Forward PE	61.66	24.18	29.60	41.04	-	-
PS Ratio	6.17	3.02	4.27	6.47	2.35	2.08
PB Ratio	3.89	1.90	3.11	4.53	2.27	1.80
P/TBV Ratio	4.12	2.02	3.15	4.59	2.27	1.80
P/FCF Ratio	-	-	-	86.62	-	14.91
P/OCF Ratio	49.45	24.18	204.86	42.06	85.30	12.59
PEG Ratio	2.29	0.87	0.77	-	-	-
EV/Sales Ratio	6.51	3.18	4.18	6.59	2.84	2.58
EV/EBITDA Ratio	130.55	62.73	32.97	49.33	22.57	27.21
EV/EBIT Ratio	-	454.59	46.50	69.52	65.22	-
EV/FCF Ratio	-	-	-	88.21	-	18.51
Debt / Equity Ratio	0.28	0.28	0.14	0.12	0.48	0.41
Debt / EBITDA Ratio	8.82	8.82	1.49	1.23	3.96	5.05
Debt / FCF Ratio	-	-	-	2.21	-	3.43
Net Debt / Equity Ratio	0.22	0.22	0.12	0.11	0.44	0.41
Net Debt / EBITDA Ratio	6.79	6.79	1.31	1.20	3.64	4.97
Net Debt / FCF Ratio	-0.99	-0.99	-1.17	2.15	-4.58	3.38
Asset Turnover	0.45	0.45	0.57	0.59	0.57	0.48
Inventory Turnover	1.81	1.81	1.92	2.04	2.00	2.01
Quick Ratio	1.25	1.25	0.93	0.79	0.65	0.73
Current Ratio	2.45	2.45	2.83	3.04	1.35	1.65
Return on Equity (ROE)	1.61%	1.61%	8.18%	9.92%	7.95%	-9.29%
Return on Assets (ROA)	0.20%	0.20%	3.20%	3.49%	1.55%	-1.80%
Return on Capital Employed (ROCE)	0.30%	0.30%	5.90%	6.00%	3.40%	-3.90%
Earnings Yield	0.41%	0.84%	2.53%	1.74%	2.96%	-0.17%
FCF Yield	-5.64%	-11.54%	-3.33%	1.15%	-4.26%	6.71%
Buyback Yield / Dilution	-0.03%	-0.03%	-4.87%	-18.49%	-	-